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tion.1 They are used extensively for children who are
prone to rapidly calcifying xenograft valves and for
whom use of warfarin is difficult.1 However, despite
these advantages, allograft valves do ultimately fail.2
This is particularly true in children in whom progres-
sive echocardiographic failure of allograft valve
implants can reach 60% within 5 years of the original
operation.3
The cause of allograft valve failure in children and
adults is most likely multifactorial and includes
mechanical, immunologic, and other factors. Immune
mechanisms have been suggested by many to contribute
to this failure, but good functional valve models to
study this in small inbred animals are lacking.4,5 In cur-
rently existing rat models, first described by Yankah and
colleagues,6 allograft valves are implanted as an aortic
interposition graft in the descending abdominal aorta.
These valves are permanently open and nonfunctional
and thus are prone to thrombosis against the aortic
Allograft valves or homografts have many advan-tages over commercially available mechanical and
bioprosthetic valves: low transvalvular gradients, low
rates of thromboembolism, and resistance to infec-
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wall.7,8 Several attempts have been made by others to
improve on this model,8,9 but these have not resolved
the problem of the use of a nonfunctional heart valve
for research into clinical concerns.
For a heterotopic valve implant to be functional, there
must be some turbulence and reversal of blood flow in
the aorta that permits leaflet closure. In the 1950s there
were reports of aortic valve allografts implanted het-
erotopically in the descending thoracic aorta of patients
with symptomatic aortic insufficiency.10,11 In these
patients valve function was shown to be excellent early
on and even at 7 years after implantation.10 The pres-
ence of aortic insufficiency resulted in significant dias-
tolic flow reversal in the thoracic aorta, thus allowing
leaflet motion and coaptation of the implanted valve.
This technique was abandoned in humans when car-
diopulmonary bypass became available, permitting
orthotopic implantation.12
The objective of this study was to create native aor-
tic valve insufficiency (AI), thus allowing flow rever-
sal in the descending aorta of a rat. If tolerated, this
would provide a recipient animal for functional het-
erotopic aortic valve implantation in the descending
abdominal aorta. This model would represent a major
leap forward in the study of aortic valve failure
because it provides a functional valve to assess the
interaction between immunologic and mechanical
injury in allograft aortic valve failure while avoiding
the need for and difficulty of orthotopic valve
implantation.
Methods
Animals. Inbred male Lewis (RT1.Al) rats weighing 300 to
350 g were purchased from Harlan Sprague Dawley
(Indianapolis, Ind) and housed in the Medical Sciences
Animal Care Facility with food and water ad libitum for 1
week before experimentation in accordance with the guide-
lines of the Canadian Council of Animal Care.13
Echocardiography. Animals were anaesthetized with ket-
amine HCl, 100 mg/kg administered intraperitoneally (Parke
Davis), and xylazine, 5 mg/kg administered intraperitoneally
(Lloyd Laboratories). Heart rate was recorded continuously
by means of transcutaneous echocardiography (ECG).
Standard 2-dimensional, M-mode, and Doppler transthoracic
and transabdominal ECG was performed with a Hewlett-
Packard Sonos 5500 ECG machine (Hewlett-Packard
Company, Andover, Mass) equipped with an S-12 MHz
transducer (range, 5-12 MHz). All recordings were video-
taped on super-VHS (Fuji H471S, ST120) for later analysis
and image digitization. Left ventricular (LV) dimensions
were measured in a standard fashion in short-axis view at the
level of the papillary muscles by M-mode tracings.
Creation of AI in recipient Lewis rats. In anesthetized
animals a midline neck incision was used to expose the right
carotid artery (Fig 1, A). The distal common carotid artery
was ligated with 4-0 nylon suture. An arteriotomy was then
performed to allow the insertion of a 0.63-mm guide wire
with a balled tip (arrow). The wire was advanced until resis-
tance from one cusp of the aortic valve was felt. The wire was
then advanced for a few millimeters to perforate a cusp of the
aortic valve and create AI (Fig 1, B). The proximal carotid
artery was ligated with 4-0 nylon sutures, and animals were
allowed to recover for a minimum of 28 days before aortic
valve graft implantation.
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Fig 1. Artist’s rendering of the stages involved in creating this new model of functional valve implantation in rats. A,
The right carotid artery is exposed to allow the insertion of guide wire. B, This guide wire disrupts the native aortic
valve and creates acute AI. C, After 28 days of recovery, animals with compensated native AI undergo a second oper-
ation in which an aortic valve graft from a donor animal is implanted heterotopically in the abdominal aorta. 
A B C
Donor and recipient operations. Lewis recipient rats with
AI received an aortic valve transplant, as originally described
by Yankah and colleagues.4 In brief, donor aortic valve grafts
were removed with a cuff of ventricular muscle and the
ascending aorta. The coronary arteries were tied with a 9-0
nylon suture. For the recipient operation, the abdominal aorta
was mobilized from the inferior vena cava from the level of
the left renal artery almost down to the aortic bifurcation and
divided between two vascular clamps. The aortic valve allo-
graft was then interposed between the stumps of the recipient
aorta with interrupted 9-0 nylon sutures.
Histology and morphometry. Four weeks after aortic
valve implantation, the animals were killed. Native hearts and
aortic valves were evaluated by means of a Weck (OM-1206;
Pilling Weck Surgical) mounted operating microscope.
Explanted abdominal grafts were immediately fixed in 10%
buffered formalin solution for 24 hours. The tissues were then
paraffin embedded, serially sectioned (5 µm), and stained for
histologic examination (hematoxylin and eosin stain).
Tissue slides from each animal were then examined by
light microscopy (Nikon), and images were digitalized and
captured (JVC digital camera, TK1070U). Morphometric
analysis was carried out by using Adobe PhotoShop
(Microsoft) and NIH Image analyzer software on a Power PC
(G3, Apple Computer) to measure aortic valve leaflet surface
area (in square micrometers) and cell counts per area.
Statistics. Means were obtained from several animals in
each group. Data were reported as mean and SEM. An
unpaired 2-tailed Student t test was used to assess statistical
significance.
Results
Catheter injury to the native aortic valve described in
the “Methods” section is illustrated in Fig 1, A and B.
This operation was performed on 8 rats. Three rats
were subsequently killed because of clinical deteriora-
tion caused by acute congestive heart failure (62.5%
survival). Transthoracic echocardiography was per-
formed before and 1 week after injury. Catheter aortic
valve injury resulted in significant acute AI in all ani-
mals (Fig 2).
Aortic insufficiency was graded as 1+ to 4+ on the
basis of the width of the aortic insufficiency jet. The
mean jet-width ratio, which is the width of the AI jet as
a function of the diameter of the valve anulus, was 37%
and ranged from 20% to 57%. A jet-width ratio of 30%
or more was considered moderate or 2+ AI.14
Postaortic valve injury mean systolic LV dimensions
were 0.88 ± 0.08 cm compared with 0.59 ± 0.07 cm for
preaortic valve injury (P < .001). Postaortic valve
injury mean diastolic LV dimensions were 0.49 ± 0.03
cm compared with 0.36 ± 0.06 cm for preaortic valve
injury (P < .001). These echocardiographic findings are
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Fig 2. Color Doppler flow scanning of the left ventricular outflow tract (LVOT). Color-coded blood flow illustrates
a regurgitant jet (arrow) of approximately half the width of the LVOT. Ao, Aorta; LV, left ventricular cavity.
summarized in Table I. Trivial mitral regurgitation was
observed in most animals after injury.
Color flow Doppler scanning was used to assess the
direction of blood flow during both systole and diastole
in the descending abdominal aorta with reference to
surface electrocardiographic tracings. Diastolic aortic
flow reversal was present in all animals after aortic
injury (Fig 3, b) as compared with control animals (Fig
3, a) in which minimal flow reversal was only seen at
the time of aortic valve closure (end-systole). Flow
reversal within the descending aorta in animals with AI
persisted throughout diastole and reached peak veloci-
ties of 0.4 m/s.
Animals with created AI (n = 5) were allowed to
recover for a minimum of 28 days, after which Lewis
aortic valve grafts were implanted infrarenally (Fig 1,
C). All animals tolerated this second surgical interven-
tion in the setting of compensated acute AI.
Echocardiography was then performed to evaluate the
abdominal implant. Valve leaflets of the abdominal
implant were visualized by 2-dimensional and M-mode
echocardiography. The appropriate opening and clos-
ing of the leaflets was demonstrated by M-mode trac-
ings during the cardiac cycle in an animal with created
native aortic insufficiency (Fig 4).
Four weeks after abdominal valve graft implantation,
animals were killed, and the abdominal implanted
valve was processed for histologic evaluation. All ani-
mals showed some disruption of one leaflet or sinus of
Valsalva of their injured native aortic valve with gross
cardiomegaly when evaluated under the dissecting
microscope (Table II). Abdominal implants were patent
(100%) and had no evidence of thrombosis.
Histologically, valve leaflets appeared normal, thin,
and cellular and were visualized in all cases (Fig 5).
Leaflet cellular density was evaluated by morphometry
and shown to be 23.3 × 103 ± 5.4 × 103 cells/µm2 in
valves 4 weeks after implantation (Fig 5).
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Fig 3. Doppler tracing sampled from the abdominal aorta of an animal without aortic injury (a) and with created
aortic injury (b). Systole and diastole were defined on the basis of a concomitant ECG tracing. An upper deflec-
tion of the Doppler tracing from baseline represented blood flow reversal toward the heart, whereas a lower deflec-
tion from baseline represented forward blood flow toward the lower extremities. The arrow indicates significant
diastolic flow reversal seen in animals after aortic valve injury (b) compared with animals without aortic valve
injury (a). D, Diastole; S, systole.
Table I. Echocardiographic results before and after aortic valve injury 
Before injury After injury P value
AI 0 2+ to 3+ —
Jet width 0 37% (20%-57%) —
Mean diastolic dimensions (cm) 0.59 ± 0.07 0.88 ± 0.08 <.001
Mean systolic dimensions (cm) 0.36 ± 0.06 0.49 ± 0.03 <.001
Mean heart rate (beats/min) 310 ± 58 253 ± 16 .06
There were 8 animals in the preinjury group and 5 animals in the postinjury group.
Comment
The availability of genetically identical inbred strains
make small-animal models essential to evaluate the
role of immunologic processes involved in allograft
valve rejection and failure. Current rat models of
infrarenal aortic valve implantation are well described
and have provided important advances in our under-
standing of allograft failure.4 However, despite having
leaflets present in the blood stream, these leaflets are
not functional and therefore are not completely repre-
sentative of human allograft failure. In existing small-
animal models, leaflets are prone to thrombosis against
the adjacent aorta and fail unusually early compared
with the clinical experience.7,8
Early work by Lam and colleagues15 in larger ani-
mals showed that experimentally it was possible to
place an allograft aortic valve in the descending aorta.
This was performed distal to the left subclavian artery
and allowed a simpler operation without cardiopul-
monary bypass support. For the transplanted valve to
function normally, sufficient native AI was necessary.
In 1956, Murray11 implanted a homograft aortic valve
in the descending thoracic aorta of a patient with severe
aortic insufficiency. Although this operation had very
little effect on the regurgitation from the head vessels
and upper extremities, it did prevent regurgitation from
the aorta distal to the implant. This resulted in a con-
siderable reduction on the strain placed on the left ven-
tricle by the constant volume overload of AI. Valve
implant function was shown to be excellent early and at
up to 7 years of follow-up.10
Aortic valve leaflet injury models are well-estab-
lished models of AI used to study the progressive
development of volume overload–dependent conges-
tive heart failure.16-18 In the rat a right carotid catheter
injury has been shown to be reliable and well tolerated
by animals with a single leaflet injury.19 In our animals
we reliably created native AI, which was assessed by
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Fig 4. M-mode echocardiographic tracing sampled from the abdominal implant in an animal with AI. Arrows point
to aortic leaflets of a valve implant appearing within the lumen of the aorta at regular intervals during the cardiac
cycle. AoW, Walls of the aorta.
Table II. Pathologic evaluation of hearts from animals that have survived creation of AI and an abdominal valve
implant
Animal Harvest Heart Aortic valve pathology
1 4 wk ++ Cardiomegaly Perforated leaflet
2 4 wk ++ Cardiomegaly Sinus of Valsalva aneurysm + right atrial fistula
3 4 wk ++ Cardiomegaly Perforated leaflet
4 4 wk ++ Cardiomegaly Torn leaflet at commissure
5 4 wk ++ Cardiomegaly Perforated leaflet
echocardiography. Previous reports have demonstrated
the accuracy and reproducibility of transthoracic
echocardiography in small animals.20 In our study,
classic findings of AI were demonstrated and included
the following: ventricular dilatation (diastolic and sys-
tolic LV dimensions); regurgitant jet from the aortic
valve; and the presence of diastolic flow reversal in the
descending aorta.14,21 Diastolic flow reversal was
shown to be present throughout the aorta down to
below the renal arteries compared with control animals
in which no native AI was present. It is this flow rever-
sal during diastole that theoretically allows leaflets to
move and function during the cardiac cycle.
Lewis rats tolerated the procedure relatively well
because a significant number of them (62.5%) under-
went an additional procedure where an abdominal
valve graft was implanted heterotopically below the
renal arteries. Valve implantation was delayed for 4
weeks to allow the animals to recover. This period of
time presumably allowed some compensation of the
heart to occur in response to the acute volume overload
created by acute aortic valve injury and resulted in
compensated AI with significant aortic diastolic flow
reversal by 1 month.
Abdominal valve grafts, when explanted and exam-
ined histologically 4 weeks after implantation, all
showed preservation of leaflet morphology with 100%
patency. Valve leaflet morphology has largely been
ignored from most previous studies that have used a rat
heterotopic valve graft model. Most previous work has
focused on the valve conduit rather than the leaflets. In
fact, in the original model leaflets were not functional,
were permanently open, and were prone to retrovalvu-
lar thrombosis. This retrovalvular thrombosis presents
3 major problems in a model of allograft valve failure.
First, it renders the interpretation of the molecular and
cellular events leading to valve failure in the rat model
much more difficult. Second, it makes extrapolation of
the data from the model to the human situation more
tenuous. Third, it results in early graft failure, which
could provide misleading information regarding the
cause of leaflet destruction. Thus, the availability of a
functional valve model is of critical importance.
We have also described a method by which leaflet
cellular density can be quantified and used to evaluate
leaflet preservation and integrity. This method could
also be applied to evaluate infiltration by various
immune effector cells by using standard immunocyto-
chemical techniques. Cellular density appears to be
particularly important in the evaluation of allograft fail-
ure because human and larger animal allograft valves
have been shown to undergo loss of leaflet stromal cells
by mechanisms that largely remain unclear.22,23 Taken
together, this modification of a heterotopic heart valve
implantation model, originally described by Yankah
and colleagues,6 has the potential to increase our
understanding of immune-mediated damage of allo-
graft heart valve.
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Fig 5. Representative photomicrographs taken from a harvested abdominal aortic valve graft 4 weeks after implan-
tation. A, Low-power (40×) cross section through the valve graft showing a normal 3-cusp valve. B, High-power
(200×) view of one of the leaflets demonstrating a normal cellularity, which can be quantified by nuclear counts
per surface area. Arrows, Leaflets; asterisks, sinuses.
Despite a small number of animals, this study repre-
sents the first evidence of a functional allograft aortic
valve transplant in an inbred small-animal model. This
improved model approaches a normal physiologically
functioning valve. By using this functional model, we
are hopeful that the various factors contributing to allo-
graft valve failure can be successfully isolated, leading
to successful therapeutic applications.
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